who owns stock in regeneron

Will Regeneron be worth more than Amazon by 2030?

11 rows · Find out the direct holders, institutional holders and mutual fund holders for Regeneron Pharmaceuticals, Inc. (REGN).

What company produces Regeneron?

158 rows · Who owns Regeneron Pharmaceuticals? Add alert for REGN Ticker: REGN; CUSIP Number: ... Download as csv Download as Excel. Top investors of Regeneron Pharmaceuticals stock. Who bought or sold Regeneron Pharmaceuticals this quarter? Fund or Company Name Shares Held Valued At Change in Shares As Of ; FMR : 11M $6.7B 1% :

Does DeSantis own Regeneron stock?

Regeneron Pharmaceuticals (NASDAQ: REGN) is owned by 82.97% institutional shareholders, 37.12% Regeneron Pharmaceuticals insiders, and 0.00% retail investors. Sanofi is the largest individual Regeneron Pharmaceuticals shareholder, owning 36.52M shares representing 33.65% of the company.

What drug company makes Regeneron?

Mar 22, 2022 · View institutional stock ownership, mutual fund ownership, and top individual ownership of REGENERON PHARMACEUTICALS, INC. (REGN).

Can I buy stock in Regeneron?

Buy Regeneron Pharmaceuticals shares from these brokerages Trade stocks in the app or online with $0 commissions. Not available in NY, NV, MN, or TN. Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.

Is Regeneron stock undervalued?

Severe undervaluation of REGN I believe REGN is severely undervalued by the market at this point. On every relevant valuation metric, it's far below the sector median: P/E ratio at 10.31, EV/Sales at 4.74, and Price/Sales at 4.93.Oct 4, 2021

Why is Regeneron stock so high?

Summary. Regeneron has grown at a rapid pace over the past few years, but still has room to grow due to its great management team and strong pipeline. Regeneron trades at very low multiples in regard to its net income and free cash flow, which presents a major opportunity as it continues to grow and expand operations.Feb 22, 2022

Who are Regeneron investors?

Largest shareholders include Fmr Llc, BlackRock Inc., Vanguard Group Inc, Capital World Investors, State Street Corp, Jpmorgan Chase & Co, Wellington Management Group Llp, VTSMX - Vanguard Total Stock Market Index Fund Investor Shares, Loomis Sayles & Co L P, and VFINX - Vanguard 500 Index Fund Investor Shares.

Is Regeneron a buy Zacks?

See rankings and related performance below. The VGM Score are a complementary set of indicators to use alongside the Zacks Rank....Momentum Scorecard. More Info.Zacks RankDefinitionAnnualized Return1Strong Buy24.93%2Buy18.44%3Hold9.99%4Sell5.61%2 more rows

Is Regeneron stock overvalued?

Regeneron Pharmaceuticals Stock Is Estimated To Be Modestly Undervalued. The stock of Regeneron Pharmaceuticals (NAS:REGN, 30-year Financials) is believed to be modestly undervalued, according to GuruFocus Value calculation.Jun 6, 2021

Is Regeneron a good investment?

Regeneron ( REGN 2.36% ) has been one of the better-performing biotech giants in the past year, with the company's shares rising by 33% in the past 12 months compared to the S&P 500's gains of about 9%.Mar 11, 2022

Is Regeneron publicly traded?

On what exchange does Regeneron trade and what is its ticker symbol? Shares of our common stock are listed on The NASDAQ Global Select Market under the symbol REGN.

Who is the CEO of Regeneron?

Leonard Schleifer (1988–)Regeneron Pharmaceuticals / CEOLeonard S. Schleifer is the co-founder and chief executive of the biotechnology company Regeneron Pharmaceuticals. Wikipedia

Is Regeneron in Ireland?

Regeneron's state-of-the-art Industrial Operations and Product Supply (IOPS) facility in Limerick is the largest bulk biologics production facility in Ireland.

What is the antibody cocktail for Covid?

REGEN-COV (casirivimab and imdevimab) is a cocktail of two monoclonal antibodies that was designed specifically to block infectivity of SARS-CoV-2, the virus that causes COVID-19, using Regeneron's proprietary VelocImmune® and VelociSuite® technologies.Nov 12, 2021